ICMR Releases Application Form For Testing Of Vector Control Products

Mumbai: In a significant development aimed at enhancing public health initiatives, the Indian Council of Medical Research (ICMR) has unveiled an application form for the testing of vector control products. This move comes as part of the ongoing efforts to combat vector-borne diseases effectively.

Vector-borne diseases pose a significant threat to public health worldwide, with India being no exception. To address this challenge, ICMR has been actively involved in evaluating the efficacy and safety of vector control products. The newly released application form is expected to streamline the process for manufacturers and applicants seeking approval for their products.

The application form outlines the evaluation criteria and requirements for testing vector control products. It emphasizes the importance of integrated vector management as a cost-effective and sustainable strategy for disease prevention. Chemical control methods, including indoor residual spraying, larvicides, space spray products, and insecticide-treated nets, are highlighted as key components of vector control efforts.

Central to the application process is the need for data on human and environmental safety, efficacy, and quality of vector control products. Manufacturers and applicants are required to submit comprehensive documentation to support their applications, including data from laboratory and multi-center field trials.

Furthermore, the application form aligns with the “Common Protocol for Uniform Evaluation of Public Health Pesticides for use in Vector Control, Third Edition (2023),” ensuring consistency and standardization in the evaluation process. The form also allows for flexibility, with the possibility of additional information or documents being requested by ICMR as deemed necessary.

The release of the application form underscores ICMR’s commitment to ensuring the effectiveness and safety of vector control products used in disease control efforts. By establishing clear guidelines and requirements, the form aims to expedite the evaluation process while maintaining rigorous standards.

As vector-borne diseases continue to pose a significant public health challenge, the importance of robust testing and evaluation mechanisms cannot be overstated. With the introduction of the application form, ICMR takes a proactive step towards strengthening vector control efforts and safeguarding public health across India.

For manufacturers and applicants seeking to submit their products for evaluation, the application form provides a structured framework to navigate the process effectively. By adhering to the guidelines outlined in the form, stakeholders can contribute to the ongoing efforts to combat vector-borne diseases and protect communities from their adverse effects.

The release of the application form marks a significant milestone in India’s public health landscape, demonstrating ICMR’s commitment to advancing vector control strategies and promoting the well-being of its citizens.

Related Posts

  • Pharma
  • July 26, 2024
  • 115 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 107 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD